$LRMR insider trading

Over the last 12 months, Larimar Therapeutics insiders reported 13 buys totaling $26.1M and no sales across SEC Form 4 filings.

$26.1M
—
13
9
0%
Side
$1K$10K$100K$1.0MAug '26SepOctNov
Hamilton Thomas Edward
THOMAS FRANK E
SHERMAN JEFFREY W
Flynn James E
Celano Michael

All insider trades

Scroll the table sideways for price, value and marks.

Nov 16, 2026SHERMAN JEFFREY W▲ Buy3,289.474$3.06$10K+65.8%
Nov 12, 2026Hamilton Thomas Edward▲ Buy70,000$2.67$187K—
Nov 11, 2026BEN-MAIMON CAROLE▲ Buy18,050$2.77$50K+4.9%
Nov 11, 2026THOMAS FRANK E▲ Buy8,000$2.72$22K+114.3%
Nov 11, 2026Truitt Joseph▲ Buy3,500$2.8$10K+127.3%
Nov 11, 2026Harlow John B. Jr.▲ Buy17,800$2.8$50K+35.6%
Nov 11, 2026Celano Michael▲ Buy18,460$2.71$50K+8.6%
Nov 11, 2026Shankar Gopi▲ Buy5,000$2.71$14K+6.5%
Jul 6, 2026Hamilton Thomas Edward▲ Buy50,000$3.34$167K+7.5%
Feb 27, 2026Flynn James E▲ Buy5,000,000$5$25.0M+413.9%
Feb 27, 2026Hamilton Thomas Edward▲ Buy100,000$5$500K+17.7%
Feb 27, 2026THOMAS FRANK E▲ Buy5,000$5$25K+250%
Feb 27, 2026SHERMAN JEFFREY W▲ Buy5,000$5$25K—

Every $LRMR filing on this page is one API call away

The same Form 4 data over REST or MCP, already grouped into events with the plan flag and the dollar value read. A free key does 100 calls a day and needs no card. Prefer email? Larimar Therapeutics filings can reach your inbox instead.

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. This page shows open-market activity: purchases (code P), sales (S) and dispositions back to the issuer (D). Scheduled compensation events such as stock grants and option exercises are also filed on Form 4 but carry no trading signal, so they are not shown and counts here can be lower than the raw EDGAR filing total. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $LRMR feed.